Six months of hormone replacement therapy does not influence muscle strength in postmenopausal women
- PMID: 12161047
- DOI: 10.1016/s0378-5122(02)00079-8
Six months of hormone replacement therapy does not influence muscle strength in postmenopausal women
Abstract
Objectives: Postmenopausal hormone replacement therapy (HRT) has positive effects on fracture incidence before any effects on bone mineral density can be demonstrated. This has been attributed to increased muscle strength by HRT. This study was designed to evaluate the effect of 6 months of HRT on muscle strength in postmenopausal women.
Methods: Forty postmenopausal women, aged 60-78 were included in the study. They were randomly divided in two groups with 20 women in each group. One group received Menorest 50 microg/24 h (estradiol 4.3 mg) and Gestapuran 2.5 mg (medroxyprogesteron) daily and the other group received placebo treatment. The study was conducted as a double blinded, prospective and placebo controlled trial. Hand grip strength, isokinetic knee flexion and extention, and physical activity were measured before treatment, after 3 and 6 months. Physical activity was estimated using a classification system of physical activity. A JAMAR hydraulic hand dynamometer and a Cybex II dynamometer were used to evaluate muscle strength.
Results: Hand grip strength in the right hand, increased significantly in both groups (HRT P<0.001 and placebo P<0.01) and in the left hand in the HRT group (P<0.01). However, there were no differences in muscle strength between the two groups. There was no significant change in isokinetic knee flexion or extension after 6 months in either of the groups. The estimated physical activity increased slightly in the placebo group, but there was no significant difference compared to the treatment group.
Conclusions: Our data suggest that 6 months of HRT does not influence muscle strength in postmenopausal women.
Similar articles
-
HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women.Maturitas. 1997 Mar;26(2):139-49. doi: 10.1016/s0378-5122(96)01098-5. Maturitas. 1997. PMID: 9089564 Clinical Trial.
-
Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.JAMA. 2002 Nov 13;288(18):2282-92. doi: 10.1001/jama.288.18.2282. JAMA. 2002. PMID: 12425705 Clinical Trial.
-
Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study.Clin Sci (Lond). 2001 Aug;101(2):147-57. Clin Sci (Lond). 2001. PMID: 11473488 Clinical Trial.
-
Postmenopausal HRT and tibolone in relation to muscle strength and body composition.Maturitas. 2007 Sep 20;58(1):7-18. doi: 10.1016/j.maturitas.2007.04.012. Epub 2007 Jun 18. Maturitas. 2007. PMID: 17576043 Review.
-
The effects of estradiol valerate plus medroxyprogesterone acetate and conjugated estrogens plus medrogestone on climacteric symptoms and metabolic variables in perimenopausal women.Acta Obstet Gynecol Scand. 1996 Apr;75(4):386-93. doi: 10.3109/00016349609033337. Acta Obstet Gynecol Scand. 1996. PMID: 8638462 Review.
Cited by
-
Catechol-o-methyltransferase gene polymorphism is associated with skeletal muscle properties in older women alone and together with physical activity.PLoS One. 2008 Mar 19;3(3):e1819. doi: 10.1371/journal.pone.0001819. PLoS One. 2008. PMID: 18350156 Free PMC article.
-
Persistent breast pain following breast cancer surgery is associated with persistent sensory changes, pain interference, and functional impairments.J Pain. 2014 Dec;15(12):1227-37. doi: 10.1016/j.jpain.2014.08.014. J Pain. 2014. PMID: 25439318 Free PMC article.
-
Identification of patient subgroups and risk factors for persistent breast pain following breast cancer surgery.J Pain. 2012 Dec;13(12):1172-87. doi: 10.1016/j.jpain.2012.09.013. J Pain. 2012. PMID: 23182226 Free PMC article.
-
Association of Hormonal Exposures With Grip Strength in Women >45 Years: Data From the CONSTANCES Cohort Study.J Endocr Soc. 2024 Sep 9;8(10):bvae150. doi: 10.1210/jendso/bvae150. eCollection 2024 Aug 27. J Endocr Soc. 2024. PMID: 39290336 Free PMC article.
-
Determinants of changes in bone mass and femoral neck structure, and physical performance after menopause: a 9-year follow-up of initially peri-menopausal women.Osteoporos Int. 2005 Jun;16(6):616-22. doi: 10.1007/s00198-004-1724-0. Epub 2004 Sep 8. Osteoporos Int. 2005. PMID: 15365700 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources